FAQ

Frequently asked questions

When will mass production of the Russian vaccine start?
In 2020, mass production of Sputnik V was launched in Russia and abroad. So far, more than 14 countries have announced the vaccine production launch, including India, China, Brazil, Mexico, Egypt, Iran, Italy, South Korea, Argentina, Kazakhstan, the Republic of Belarus, Serbia, Turkey, Vietnam, etc.

Will the vaccine be available in other countries?
Sputnik V has been approved for use in 71 countries with a total population of 4 billion people. The list of countries includes the Americas, the Middle East, Europe, Asia and Africa. The list is expected to expand. Vaccination with Sputnik V is underway in more than 50 countries on 4 continents, including Argentina, Hungary, Bolivia, Algeria, Montenegro, Paraguay, etc.

For information on when Sputnik V is available in your country, subscribe to the Sputnik V social media news feeds.

When will Russia provide full scientific data behind the vaccine?
The vaccine Phase I–II and Phase III clinical trials analysis was published in The Lancet , one of the leading international medical magazines.

When will the vaccine be available?
Sputnik V is available for the population of Russia and other countries where the regulatory authority has approved the vaccine application within the national anti-COVID-19 mass vaccination program. Russia has launched Sputnik V serial production at different in-country facilities, primarily for domestic use. Our international partners are currently manufacturing Sputnik V for foreign use. Subscribe to Sputnik V social media feeds to see Sputnik V international production and distribution data.

How to obtain/purchase the vaccine?
Sputnik V will be allowed for use by a certain country’s population after being approved by the respective regulatory authority within the national anti-COVID-19 mass vaccination program. Subscribe to Sputnik V social media feeds to see Sputnik V international production and distribution data.

What will be the price of Sputnik V vaccine?
Production costs and logistics will be the factors affecting the price for specific countries. In many countries, e. g. Russia, national medical insurance programs will cover the vaccination costs. As we are not aiming at extra high profits from the vaccine sales, the price will be competitive, max $10/dose. Subscribe to Sputnik V social media feeds to get more details.


Message has been successfully sent!

Thank you!
You have been subscribed